CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 397 filers reported holding CRISPR THERAPEUTICS AG in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $659,653 | +55.4% | 14,533 | +92.2% | 0.02% | +88.9% |
Q2 2023 | $424,531 | +24.1% | 7,562 | 0.0% | 0.01% | +28.6% |
Q1 2023 | $342,029 | +89202.6% | 7,562 | -19.8% | 0.01% | +16.7% |
Q4 2022 | $383 | -100.0% | 9,434 | -24.7% | 0.01% | -45.5% |
Q3 2022 | $819,000 | +3.1% | 12,526 | -4.2% | 0.01% | +37.5% |
Q2 2022 | $794,000 | +61.4% | 13,071 | +66.8% | 0.01% | +60.0% |
Q1 2022 | $492,000 | – | 7,835 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |